You need this when

Your team needs to stay current in a defined domain, but nobody has time to read everything — and the databases you already pay for produce more noise than signal.

What you get

1. Defined perimeter. We agree precisely what you want tracked: therapeutic areas, modalities, geographies, competitor set, deal types.

2. Automated monitoring at scale. Our proprietary pipeline continuously ingests global pharma and biotech sources — deals, clinical readouts, funding rounds, pipeline movements, regulatory events.

3. Expert filtering. This is the part that matters. Every item that reaches you has passed a human filter applied by someone with BD&L and R&D experience. Volume is handled by machines; relevance is not.

4. Strategic synthesis. Beyond the items themselves: what the pattern means. Which movements are noise, which signal a shift worth acting on.

5. Direct access. A channel to ask follow-up questions on anything in the feed.

Format

• Cadence: [weekly / bi-weekly] digest + [monthly] synthesis
• Deliverable: written digest + periodic strategic note
• Investment: from € 3'000/month
• Commitment: [3-month minimum, then rolling]

Why not just use a database?

Enterprise intelligence platforms are excellent at coverage and poor at judgement. They tell you everything happened. They cannot tell you which three things matter to your pipeline this quarter — because that requires knowing your pipeline, and having the experience to weigh a signal against it.

You are not buying data. You are buying the filter.